Litcius/Paper detail

COVID-19 infection can cause chemotherapy resistance development in patients with breast cancer and tamoxifen may cause susceptibility to COVID-19 infection

Hülya Vatansev, Cengiz Kadıyoran, Medine Cumhur Cüre, Erkan Cüre

2020Medical Hypotheses25 citationsDOIOpen Access PDF

Topics & Concepts

TamoxifenBreast cancerAntiestrogenEstrogen receptorEstrogenInternal medicineEndocrinologyCancer researchMedicineAngiotensin IICancerBiologyReceptorCancer Immunotherapy and BiomarkersCancer, Stress, Anesthesia, and Immune ResponseLung Cancer Research Studies
COVID-19 infection can cause chemotherapy resistance development in patients with breast cancer and tamoxifen may cause susceptibility to COVID-19 infection | Litcius